Walgreens CEO Tim Wentworth at #JPM24 (Brian Benton Photography)
April 25, 2024 12:01 AM EDT
Cell/Gene Tx
Health Tech

Wal­greens will build out spe­cial­ty phar­ma­cy busi­ness, lean­ing in­to drug and ther­a­py ser­vices

Lydia Ramsey Pflanzer

Deputy Editor

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Wal­greens said Thurs­day it� …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

RFK Jr. touts CMS pro­gram test­ing new ways to pay for sick­le cell dis­ease treat­ment

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times